A Ram Kim (Aram Kim)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Optical Coherence Tomography

Lipopolysaccharide Induced

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Kwang-Soo Lee, Yunsik Kim, Jin Hee Lee, Suji Shon, A Ram Kim, An Vuong Quynh Pham, Chungho Kim, Dong Hyun Kim, Yoon-Keun Kim, Eun-Gyung Cho
Human Probiotic Lactobacillus paracasei -Derived Extracellular Vesicles Improve Tumor Necrosis Factor-α-Induced Inflammatory Phenotypes in Human Skin. Cells 12 (24) (2023)
Kwang-Soo Lee, Yunsik Kim, Jin Hee Lee, Suji Shon, A Ram Kim, An Vuong Quynh Pham, Chungho Kim, Dong Hyun Kim, Yoon-Keun Kim, Eun-Gyung Cho
Human Probiotic Lactobacillus paracasei -Derived Extracellular Vesicles Improve Tumor Necrosis Factor-α-Induced Inflammatory Phenotypes in Human Skin. Cells 12 (24) (2023)
Kwang-Soo Lee, Yunsik Kim, Jin Hee Lee, Suji Shon, A Ram Kim, An Vuong Quynh Pham, Chungho Kim, Dong Hyun Kim, Yoon-Keun Kim, Eun-Gyung Cho
Human Probiotic Lactobacillus paracasei -Derived Extracellular Vesicles Improve Tumor Necrosis Factor-α-Induced Inflammatory Phenotypes in Human Skin. Cells 12 (24) (2023)
Kwang-Soo Lee, Yunsik Kim, Jin Hee Lee, Suji Shon, A Ram Kim, An Vuong Quynh Pham, Chungho Kim, Dong Hyun Kim, Yoon-Keun Kim, Eun-Gyung Cho
Human Probiotic Lactobacillus paracasei -Derived Extracellular Vesicles Improve Tumor Necrosis Factor-α-Induced Inflammatory Phenotypes in Human Skin. Cells 12 (24) (2023)
Kwang-Soo Lee, Yunsik Kim, Jin Hee Lee, Suji Shon, A Ram Kim, An Vuong Quynh Pham, Chungho Kim, Dong Hyun Kim, Yoon-Keun Kim, Eun-Gyung Cho
Human Probiotic Lactobacillus paracasei -Derived Extracellular Vesicles Improve Tumor Necrosis Factor-α-Induced Inflammatory Phenotypes in Human Skin. Cells 12 (24) (2023)
Bo Ram Mok, Su-Ji Shon, A Ram Kim, Carolyne Simard-Bisson, Israël Martel, Lucie Germain, Dong Hyun Kim, Jung U Shin
Structural and Functional Validation of a Full-Thickness Self-Assembled Skin Equivalent for Disease Modeling. Pharmaceutics 14 (6) (2022)